A Multicentre Randomized Phase II Trial Comparing Nab-Paclitaxel to Paclitaxel in Patients With Advanced Urothelial Cancer Progressing on or After a Platinum Containing Regimen.
The purpose of this study is to compare the effects on urothelial cancer of nab-paclitaxel
compared to paclitaxel to treat this disease.
This research is being done because currently there is no effective treatment for urothelial
cancer that has progressed after prior chemotherapy.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society